Bioethics News

Human Gene Editing Therapies Are OK in Certain Cases, Panel Advises

Expert group recommends long-term tracking, other restrictions for germline tinkering. Jeffrey Kahn, a bioethicist at Johns Hopkins University, says the door to heritable gene therapy remains closed until stringent requirements can be met. “It’s frankly more of a knock on the door,” he said at the public presentation of the report

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.